Sign up
for early access to our Black Friday deals, exclusive contents, and new product launches.
The brand
Les produits SVR
30% urea foot cream.
Tested under dermatological control.
Spreads and absorbs easily.
(1) Corneometry tests, 11 volunteers
INCI: 090129 - INGREDIENTS (CONTAINS): AQUA (PURIFIED WATER), UREA, GLYCERIN, BUTYROSPERMUM PARKII BUTTER (SHEA BUTTER), OCTYLDODECANOL, CETEARYL ETHYLHEXANOATE, ISOHEXADECANE, POLYACRYLATE-13, SILICA DIMETHYL SILYLATE, TRIETHANOLAMINE, PANTHENOL, SALICYLIC ACID, SERINE, ALLANTOIN, BACILLUS FERMENT, HISTIDINE, POLYISOBUTENE, OCTYLDODECYL XYLOSIDE, PEG-30 DIPOLYHYDROXYSTEARATE, POLYSORBATE 20, SORBITAN ISOSTEARATE, PROPYLENE GLYCOL, CITRIC ACID, DISODIUM EDTA, POTASSIUM SORBATE.
The list of ingredients may be subject to change, we advise you to check the list on the purchased product.
Massage all over feet daily using circular motions.
Do not use on children under three.
Read the leaflet carefully before use.
Complete your routine with our XERIAL Peel Exfoliating Socks and Xerial 40 Nourishing Nail Treatment.
SVR
is committed to Endocrine Disruptors
Because SVR is a dermocosmetics laboratory with a large family audience and concerned about the safety and tolerance of its products (which are already subject to a drastic charter), we wanted to provide our consumers with concrete answers, through a series of tests carried out on our formulas. These tests were carried out on the estrogenic, androgenic and thyroid endocrine mechanisms.
A strong initiative that seemed legitimate to us in view of SVR's dermatological positioning and the precautionary principle that the laboratory must adopt. An essential initiative to enlighten consumers who trust us about the products they use on a daily basis. Of course, science still needs to make progress on knowledge of endocrine disruptors and we need to move modestly on these issues. But that doesn’t stop SVR from making a contribution. This is why we continually strive to improve our formulas, in order to guarantee our consumers the safest possible products.
The objective is to test SVR care that is aimed at the most vulnerable people and to reformulate those that will not be validated by the tests.
